Transgenomic Return on Tangible Equity 2010-2023 | PRPO
Current and historical return on tangible equity values for Transgenomic (PRPO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Transgenomic Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-0.01B |
$0.00B |
-500.00% |
| 2023-09-30 |
$-0.01B |
$0.00B |
-640.00% |
| 2023-06-30 |
$-0.01B |
$0.00B |
-444.44% |
| 2023-03-31 |
$-0.01B |
$0.00B |
-285.71% |
| 2022-12-31 |
$-0.01B |
$0.00B |
-228.57% |
| 2022-09-30 |
$-0.01B |
$0.00B |
-171.43% |
| 2022-06-30 |
$-0.01B |
$0.01B |
-125.71% |
| 2022-03-31 |
$-0.01B |
$0.01B |
-117.07% |
| 2021-12-31 |
$-0.01B |
$0.01B |
-100.00% |
| 2021-09-30 |
$-0.01B |
$0.01B |
-160.00% |
| 2021-06-30 |
$-0.01B |
$0.01B |
-514.29% |
| 2021-03-31 |
$-0.01B |
$-0.00B |
355.56% |
| 2020-12-31 |
$-0.01B |
$-0.00B |
430.77% |
| 2020-09-30 |
$-0.02B |
$-0.00B |
457.14% |
| 2020-06-30 |
$-0.02B |
$-0.00B |
400.00% |
| 2020-03-31 |
$-0.02B |
$-0.01B |
475.00% |
| 2019-12-31 |
$-0.01B |
$-0.00B |
280.00% |
| 2019-09-30 |
$-0.02B |
$-0.00B |
226.67% |
| 2019-06-30 |
$-0.02B |
$-0.01B |
190.00% |
| 2019-03-31 |
$-0.02B |
$-0.01B |
136.17% |
| 2018-12-31 |
$-0.02B |
$-0.01B |
163.27% |
| 2018-09-30 |
$-0.03B |
$-0.01B |
216.67% |
| 2018-06-30 |
$-0.03B |
$-0.01B |
266.67% |
| 2018-03-31 |
$-0.04B |
$-0.01B |
298.04% |
| 2017-12-31 |
$-0.03B |
$-0.01B |
216.39% |
| 2017-09-30 |
$-0.02B |
$-0.01B |
138.18% |
| 2017-06-30 |
$-0.01B |
$-0.02B |
59.02% |
| 2017-03-31 |
$0.00B |
$-0.02B |
0.00% |
| 2016-12-31 |
$-0.00B |
$-0.01B |
20.34% |
| 2016-09-30 |
$-0.02B |
$-0.02B |
143.28% |
| 2016-06-30 |
$-0.03B |
$-0.02B |
261.22% |
| 2016-03-31 |
$-0.04B |
$-0.02B |
388.89% |
| 2015-12-31 |
$-0.03B |
$-0.01B |
566.67% |
| 2015-09-30 |
$-0.02B |
$-0.00B |
2000.00% |
| 2015-06-30 |
$-0.01B |
$-0.00B |
600.00% |
| 2015-03-31 |
$-0.01B |
$-0.01B |
577.78% |
| 2014-12-31 |
$-0.01B |
$0.01B |
933.33% |
| 2014-09-30 |
$-0.01B |
$-0.01B |
282.35% |
| 2014-06-30 |
$-0.02B |
$-0.01B |
553.85% |
| 2014-03-31 |
$-0.02B |
$-0.00B |
1700.00% |
| 2013-12-31 |
$-0.02B |
$-0.01B |
-1360.00% |
| 2013-09-30 |
$-0.02B |
$-0.00B |
-461.54% |
| 2013-06-30 |
$-0.01B |
$0.00B |
-266.67% |
| 2013-03-31 |
$-0.01B |
$0.01B |
-160.00% |
| 2012-12-31 |
$-0.01B |
$0.00B |
-120.00% |
| 2012-09-30 |
$-0.01B |
$0.00B |
-116.67% |
| 2012-06-30 |
$-0.01B |
$0.01B |
-600.00% |
| 2012-03-31 |
$-0.01B |
$0.01B |
200.00% |
| 2011-12-31 |
$-0.01B |
$-0.00B |
102.33% |
| 2011-09-30 |
$-0.01B |
$-0.02B |
102.13% |
| 2011-06-30 |
$-0.01B |
$-0.02B |
200.00% |
| 2011-03-31 |
$-0.01B |
$-0.01B |
-800.00% |
| 2010-12-31 |
$-0.00B |
$-0.01B |
-52.17% |
| 2010-09-30 |
$-0.00B |
$0.01B |
-19.51% |
| 2010-06-30 |
$-0.00B |
$0.01B |
-9.30% |
| 2010-03-31 |
$-0.00B |
$0.01B |
-8.89% |
| 2009-12-31 |
$-0.00B |
$0.01B |
-17.39% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.008B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
